Qi Yang

发表

Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers

P. Hou, Leitai Shi, B. Shi, 2014, International journal of cancer.

Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer.

Bingyin Shi, Peng Hou, Jing Shi, 2013, Clinical biochemistry.

c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis

Juan Liu, P. Hou, B. Shi, 2017, Theranostics.

c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis

Juan Liu, P. Hou, B. Shi, 2017, Theranostics.

P. Hou, B. Shi, Qi Yang, 2018, Pathology, research and practice.

Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.

P. Hou, B. Shi, Demao Yao, 2016, Archives of medical research.

ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.

Wei Liu, P. Hou, B. Shi, 2014, The Journal of clinical endocrinology and metabolism.

Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy

Wuyuan Lu, Wangxiao He, Jin Yan, 2019, Advanced functional materials.

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival

P. Hou, B. Shi, Meiju Ji, 2019, Oncogenesis.

ACYP2 contributes to malignant progression of glioma through promoting Ca2+ efflux and subsequently activating c-Myc and STAT3 signals

P. Hou, Mingwei Chen, Meiju Ji, 2020, Journal of experimental & clinical cancer research : CR.

Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients

Wei Liu, P. Hou, B. Shi, 2015, Cell cycle.

Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients

P. Hou, B. Shi, Guanjun Zhang, 2013, Diagnostic Pathology.

Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment

P. Hou, Meiju Ji, Lihong Chen, 2021, Journal of Nanobiotechnology.

Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer

Wei Liu, P. Hou, B. Shi, 2015, Oncotarget.

Long telomere length predicts poor clinical outcome in esophageal cancer patients.

P. Hou, B. Shi, Xinru Li, 2017, Pathology, research and practice.

Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway

P. Hou, B. Shi, Meiju Ji, 2014, Cell cycle.

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients

P. Hou, B. Shi, Y. Shao, 2014, Diagnostic Pathology.

Targeting PFKFB3 in the Endothelium for Cancer Therapy.

P. Hou, Qi Yang, 2017, Trends in molecular medicine.

Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.

P. Hou, B. Shi, Meiju Ji, 2013, The Journal of clinical endocrinology and metabolism.

Analysis of BRAFV600E mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies

P. Hou, B. Shi, Zhaoxia Zhang, 2014, Diagnostic Pathology.

Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.

P. Hou, N. He, B. Shi, 2013, Journal of biomedical nanotechnology.

Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway

P. Hou, B. Shi, Meiju Ji, 2015, Oncotarget.

Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.

P. Hou, Yanfang Zhang, B. Shi, 2016, American journal of cancer research.

Emerging role of PI3K/AKT in tumor-related epigenetic regulation.

P. Hou, Wei Jiang, Qi Yang, 2019, Seminars in cancer biology.

c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer.

P. Hou, B. Shi, Mingwei Chen, 2018, Thyroid : official journal of the American Thyroid Association.

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms

P. Hou, Meiju Ji, Demao Yao, 2019, Theranostics.

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma

P. Hou, B. Shi, Meiju Ji, 2017, Oncology letters.

ACYP2 contributes to malignant progression of glioma through promoting Ca2+ efflux and subsequently activating c-Myc and STAT3 signals

P. Hou, Mingwei Chen, Meiju Ji, 2020, Journal of Experimental & Clinical Cancer Research.

Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing

P. Hou, B. Shi, Mingwei Chen, 2017, Oncotarget.

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer

P. Hou, B. Shi, Meiju Ji, 2016, Cell Death and Disease.

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients

P. Hou, B. Shi, Xiaozhi Zhang, 2017, Oncotarget.

ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer.

P. Hou, B. Shi, Meiju Ji, 2018, Cancer research.

Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis

P. Hou, Yanfang Zhang, B. Shi, 2016, The Journal of clinical endocrinology and metabolism.

NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulation

Wei Liu, P. Hou, Meiju Ji, 2020, International journal of biological sciences.

PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.

P. Hou, B. Shi, Meiju Ji, 2014, The Journal of clinical endocrinology and metabolism.

TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.

P. Hou, B. Shi, Meiju Ji, 2019, Thyroid : official journal of the American Thyroid Association.

SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis

P. Hou, B. Shi, Meiju Ji, 2018, Oncogene.

High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patients.

P. Hou, Yanfang Zhang, B. Shi, 2015, American journal of cancer research.

TERT promoter mutations predict worse survival in laryngeal cancer patients

P. Hou, B. Shi, Y. Shao, 2014, International journal of cancer.

High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAFV600E Mutation and TMPRSS4 mRNA Level.

P. Hou, Yanfang Zhang, Zhaoxia Zhang, 2018, Archives of medical research.

The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis.

P. Hou, B. Shi, Jiaxin Liu, 2018, Pathology, research and practice.

Hypoxia switches TET1 from being tumor-suppressive to oncogenic

P. Hou, Meiju Ji, Jiaxin Liu, 2023, Oncogene.

Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3

P. Hou, Yanfang Zhang, B. Shi, 2016, Oncotarget.

Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis

P. Hou, B. Shi, Meiju Ji, 2019, Oncogene.

A Feedback loop Involving Exosomal MiR-146a and NG2 to Propel the Development and Progression of Hypothyroidism.

M. Xing, Meiju Ji, Haixia Guan, 2023, Thyroid : official journal of the American Thyroid Association.

PRIMA-1 selectively induces global DNA demethylation in p53 mutant-type thyroid cancer cells.

Shu Liu, Wei Liu, P. Hou, 2014, Journal of biomedical nanotechnology.